Yi Chi Song is an Associate at Casdin Capital, LLC, specializing in biotech since August 2023, following a tenure as a Biotech Equity Research Associate at Jefferies from August 2021 to July 2023, where reported to Lead Analyst Michael Yee. Prior experience includes serving as an Analyst at Back Bay Life Science Advisors, a Business Development Intern at MedRhythms, Inc., and a Summer Analyst at Cornerstone Research. Yi Chi Song began an academic career as an Undergraduate Research Assistant in the Kumar Lab at Tufts University while pursuing a Bachelor of Science degree in Biochemistry, graduating summa cum laude in 2020, after attending Dulwich College Beijing and earning an IB Diploma.
This person is not in any teams
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.